RFA-AI-22-075: Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $1.0 million to small businesses. Applications closed on February 22, 2023.
From the official notice on Grants.gov, last changed December 15, 2022. Checked November 7, 2026.
- Award ceiling$1.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeUC7
- Clinical trialsNot allowed
- Funded byNIAID
- Median yearly award$1.0 million
- Typical project length5 years
Projects funded under RFA-AI-22-075 were run by National Institute of Allergy and Infectious Diseases (NIAID, 12 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-AI-22-075 in the NIH Guide.
Key dates
| Posted | December 14, 2022 |
|---|---|
| Deadline | February 22, 2023 |
| Archived by Grants.gov | March 30, 2023 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $1.0 million; it allows up to $1.0 million per award.
- Most of the program's money (67% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The goal of this Funding Opportunity Announcement (FOA) is to provide support to the 12 Regional Biocontainment Laboratories (RBLs) previously constructed with NIAID support to enable them to develop and maintain resources, staff, and facilities necessary to address biodefense agents, emerging infectious diseases, and pandemic preparedness in line with NIAID priorities. Operations support is provided for facility maintenance and operations, as well as Biosafety Level 3 (BSL-3) practices support for personnel working in and around BSL-3 space and associated building systems. An optional component would allow the RBLs to provide specialized services essential to support BSL3 activities. The RBLs will serve as regional resources for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense, emerging infectious diseases, and pandemic preparedness research efforts.
Funded under RFA-AI-22-075 so far
NIH funded 12 projects under RFA-AI-22-075 in fiscal 2023 to 2026, at 12 institutions. The median yearly award was $1.0 million.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| NERBL Core 2: BSL-3 Practices | Tufts University Boston | 2026 | $1.1 million |
| Biocontainment Research Support Services Core | Colorado State University | 2026 | $1.2 million |
| Integrated Services Core | University of Pittsburgh at Pittsburgh | 2026 | $879,794 |
| Facility Management, Maintenance and Operations (FMMO) Core | Rutgers Biomedical and Health Sciences | 2026 | $2.1 million |
| Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support | University of Alabama at Birmingham | 2026 | $2.6 million |
| BSL3 management and practice of infectious disease research at HTRL | University of Chicago | 2026 | $2.5 million |
| UofL RBL Pandemic Preparedness and Response Integrated Research Core | University of Louisville | 2026 | $1.8 million |
| Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory | University of Missouri-Columbia | 2026 | $2.4 million |
Who has won Allergy and Infectious Diseases Research grants before
From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Washington | 85 | $938 million |
| Duke University | North Carolina | 230 | $781 million |
| University of California, Los Angeles | California | 138 | $745 million |
| The Johns Hopkins University | Maryland | 321 | $668 million |
| Emory University | Georgia | 282 | $650 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-AI-22-075 still open?
No. It closed on February 22, 2023.
Who can apply for Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)?
Closed February 22, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each.
Who has been funded under RFA-AI-22-075?
NIH RePORTER lists 12 projects funded under RFA-AI-22-075 in fiscal 2023 to 2026, at 12 institutions. The most were at Tufts University Boston, Colorado State University, University of Pittsburgh at Pittsburgh.
Who has won Allergy and Infectious Diseases Research grants before?
The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)